Other OTC - Delayed Quote • USD
Provectus Biopharmaceuticals, Inc. (PVCT)
As of 10:26 AM EDT. Market Open.
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is S&P 500
Return | PVCT | S&P 500 |
---|---|---|
YTD | +102.92% | +6.09% |
1-Year | +39.14% | +22.42% |
3-Year | +190.75% | +22.38% |